Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 204

Sort by

Sort Order Select

Journal Articles

How I treat pain in hematologic malignancies safely with opioid therapy

Holly L. Geyer, Halena Gazelka, Ruben Mesa

Blood (2020) 135 (26): 2354–2364.

https://doi.org/10.1182/blood.2019003116

Published: 2020

Journal Articles

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Shivi Jain, MD, Laura Kavoliunaite, APN, Robert E. Molokie, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3390.

https://doi.org/10.1182/blood-2019-122249

Published: 2019

Journal Articles

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Renee Cheng, MD, Rishi Patel, MD, Sandra Kang, MD, Frances Tian, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Jayleen Patel, MD, Netanel Zilberstein, MD, Victor R Gordeuk, MD, Michel Gowhari, DO

Blood (2019) 134 (Supplement_1): 3396.

https://doi.org/10.1182/blood-2019-130877

Published: 2019

Journal Articles

Potentially Modifiable Risk Factors for 30‐Day Readmission in Adults with Sickle Cell Disease: A National Database Study

Manojna Konda, MD, Arya Mariam Roy, MD, Anusha Jillella, MD, Akshay Goel, MD, Appalanaidu Sasapu, MD

Blood (2019) 134 (Supplement_1): 4857.

https://doi.org/10.1182/blood-2019-132215

Published: 2019

Journal Articles

The Effects of Utilization of Individualized Pain Plans in Treatment of Vaso-Occlusive Crises in the Emergency Department

Sherraine Griffin, MD, Payal Desai, MD, Eric Adkins, MD MSc, Michael G (MD) Purcell, MD, Luca Delatore, MD, Ying Huang, MS, MA, Melanie Heinlein, BSc

Blood (2019) 134 (Supplement_1): 4682.

https://doi.org/10.1182/blood-2019-126991

Published: 2019

Journal Articles

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Jennifer Yui, MD, Scott A. Peslak, MD PhD, David Lambert, MD, Eric Russell, MD, Farzana Sayani, MD

Blood (2019) 134 (Supplement_1): 4678.

https://doi.org/10.1182/blood-2019-123868

Published: 2019

Journal Articles

Use of Buprenorphine/Naloxone in Ameliorating Acute Care Utilization and Chronic Opioid Use in Adults with Sickle Cell Disease

Ifeyinwa (ify) Osunkwo, MD MPH, Padmaja Veeramreddy, MD, Justin Arnall, PharmD, CPP, BCOP, Rachel Crawford, PharmD, BCPS, James T Symanowski, PhD, Rasaq Olaosebikan, MD MSc, Srinivasa Reddy Sanikommu, MD, Stephanie Newby, MD, Stephen Wyatt, DO, Jamie Sebaaly, Katherine Rector

Blood (2019) 134 (Supplement_1): 790.

https://doi.org/10.1182/blood-2019-126589

Published: 2019

Journal Articles

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

Claudia R. Morris, MD, Janet Figueroa, MPH, Amanda Watt, Kirshma Khemani, MD, Polly Kumari, MBBS, Morgan Barnett, MPH, Nitya Bakshi, MBBS, MS, Peter A. Lane, MD, Carlton Dampier, MD

Blood (2019) 134 (Supplement_1): 995.

https://doi.org/10.1182/blood-2019-122983

Published: 2019

Journal Articles

The Relationship between Mental Health, Educational Attainment, Employment Outcomes, and Pain in Sickle Cell Disease

Kelly M Harris, PhD, Taniya Varughese, MSOT, OTR/L, Anna Bauer, BA, Seth Howdeshell, MD, Cecelia Calhoun, MD, Regina Abel, PhD, Allison A. King, MD MPH, PhD

Blood (2019) 134 (Supplement_1): 419.

https://doi.org/10.1182/blood-2019-129874

Published: 2019

Journal Articles

Oral Arginine Therapy As a Novel Adjuvant in the Management of Acute Pain in Children with Sickle Cell Anemia in Nigeria: A Randomized Placebo-Controlled Trial

Richard Onalo, FCPaed, Peter Cooper, FCPaed, Antoinette Cilliers, FCPaed, Uche Nnebe-Agumadu, FCPaed, Oluseyi Oniyangi, FCPaed, Damilare Oladimeji, MSc Statistics, Claudia R. Morris, MD

Blood (2019) 134 (Supplement_1): 613.

https://doi.org/10.1182/blood-2019-122510

Published: 2019

Journal Articles

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Bart J. Biemond, MD PhD, Anil Tombak, MD, Yurdanur Kilinc, MD, Murtadha Al-Khabori, MD, Miguel R. Abboud, MD, Mohammed Nafea, MD, Adlette Inati, MD, Yasser Ahmed Mohamed Soliman Wali, MD, Jens Kristensen, MD PhD, Ellen Donnelly, PhD, John Ohd, MD PhD

Blood (2019) 134 (Supplement_1): 614.

https://doi.org/10.1182/blood-2019-124653

Published: 2019

Journal Articles

Management Strategies and Satisfaction Levels in Patients with Sickle Cell Disease: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)

John James, MSc, Biree Andemariam, MD, Baba PD Inusa, MD, Fuad El-Rassi, Beverly Francis-Gibson, Alecia C. Nero, MD, Caterina P. Minniti, MD, Cassandra Trimnell, BA, Miguel R. Abboud, MD, Jean-Benoît Arlet, Raffaella Colombatti, Mariane de Montalembert, MD PhD, Suman Jain, Wasil Jastaniah, Erfan Nur, MD PhD, Laurie DeBonnett, MD, Ifeyinwa (ify) Osunkwo, MD MPH

Blood (2019) 134 (Supplement_1): 1017.

https://doi.org/10.1182/blood-2019-123643

Published: 2019

Journal Articles

Optimizing the Economic Impact of Sickle Cell Hospitalization By Effective Care Plans

Bilawal Ahmed, MD, Kelton R Clements, Jonathan Heidt, MD, Michael Trendle, MD, Sindhu Singh, MD

Blood (2019) 134 (Supplement_1): 1023.

https://doi.org/10.1182/blood-2019-129732

Published: 2019

Journal Articles

Baseline Pain in Adults with Sickle Cell Disease Can be Neuropathic or Nociceptive and Outcomes Differ between Pain Types

Susanna A Curtis, MD, Ariadna Forray, MD, Jeanne E. Hendrickson, MD, John D. Roberts, MD

Blood (2019) 134 (Supplement_1): 1028.

https://doi.org/10.1182/blood-2019-129106

Published: 2019

Journal Articles

An Observational Study of the Prescribing Practices and Patient Reported Outcomes Measures in Older People with Myelodysplastic Syndrome

Angela Molga, MBBS, Michelle Wall, Dip HE (Nursing), BA (Hons), MSc, PG Cert, Rakchha Chhetri, MBBS, Amilia Wee, BSc (Hons), Deepak Singhal, MBBS, MDFRACP, FRCPA, Pratyush Giri, MBBS,FRACP,FRCPA, Timothy To, BSc, BMBS, FRACP, FAChPM, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2019) 134 (Supplement_1): 5426.

https://doi.org/10.1182/blood-2019-132164

Published: 2019

Journal Articles

Tiered Oral Therapy Protocol for Sickle Cell Vaso-Occlusive Crisis

Margaret Guy, MD, Lauren Magee, PharmD, BCPS, Jessica Keiser, MD, Nicole Carter, RN, MSN, NP-C, DaleMarie Vaughan, PharmD, BCPS, Chantal McHenry, BS, Daniel Sop, BS,MS, Sarah Hartigan, MD, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 3446.

https://doi.org/10.1182/blood-2019-131298

Published: 2019

Journal Articles

A Pilot Adult Sickle Cell Hematology Clinic in California's Inland Empire Improves Patient Outcome

Neha Chiruvolu, DO, Amie Patel, DO, Carolyn Rowley, PhD, Marsha J. Treadwell, PhD, Elliott P. Vichinsky, MD, Zahra Pakbaz, MD

Blood (2019) 134 (Supplement_1): 3470.

https://doi.org/10.1182/blood-2019-125160

Published: 2019

Journal Articles

Sickle-Cell Disease in Greece: Patient Reported Outcomes Related to Clinical Complications, Treatment Choices and Attitudes, Beliefs and Trends Affecting Potential Participation in Clinical Trials - a Greek National Multicentric Study

Sophia Delicou, Michael D. Diamantidis, MD PhD MSc, Konstantinos Manganas, Eftychios Eftychiadis, MD, Despoina Pantelidou, MD PhD, Alexandra Kourakli, MD PhD, Efthymia Vlachaki, MBBS, Loukia Evliati, Ioannis Lafiatis, Evangelos Klironomos, MD, Dimitra Kyriakopoulou, MD, Aikaterini Xydaki, Vassiliki Bartzi, Despoina Papadopoulou, Vasileios Lazaris, Chrysoula Apostolou, Antonis Kattamis, Argiris Symeonidis, MD PhD

Blood (2019) 134 (Supplement_1): 4838.

https://doi.org/10.1182/blood-2019-127966

Published: 2019

Journal Articles

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Raven Myrick, MSN, CRNP, Brandi Pernell, DNP, Avi Madan-Swain, PhD, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO, MSPH

Blood (2019) 134 (Supplement_1): 4691.

https://doi.org/10.1182/blood-2019-131059

Published: 2019

Journal Articles

Benefits of Aquatic Therapy in Pediatric Patients with Sickle Cell Disease

Sarah Leonard, MDMPH, Lindsay Cortright, MA, Dmitry Tumin, PhD, Lora Joyner, MS, PT, PCS, Sruthipriya Sridhar, MD

Blood (2019) 134 (Supplement_1): 4846.

https://doi.org/10.1182/blood-2019-129163

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

How I treat pain in hematologic malignancies safely with opioid therapy

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Potentially Modifiable Risk Factors for 30‐Day Readmission in Adults with Sickle Cell Disease: A National Database Study

The Effects of Utilization of Individualized Pain Plans in Treatment of Vaso-Occlusive Crises in the Emergency Department

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Use of Buprenorphine/Naloxone in Ameliorating Acute Care Utilization and Chronic Opioid Use in Adults with Sickle Cell Disease

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

The Relationship between Mental Health, Educational Attainment, Employment Outcomes, and Pain in Sickle Cell Disease

Oral Arginine Therapy As a Novel Adjuvant in the Management of Acute Pain in Children with Sickle Cell Anemia in Nigeria: A Randomized Placebo-Controlled Trial

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Management Strategies and Satisfaction Levels in Patients with Sickle Cell Disease: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)

Optimizing the Economic Impact of Sickle Cell Hospitalization By Effective Care Plans

Baseline Pain in Adults with Sickle Cell Disease Can be Neuropathic or Nociceptive and Outcomes Differ between Pain Types

An Observational Study of the Prescribing Practices and Patient Reported Outcomes Measures in Older People with Myelodysplastic Syndrome

Tiered Oral Therapy Protocol for Sickle Cell Vaso-Occlusive Crisis

A Pilot Adult Sickle Cell Hematology Clinic in California's Inland Empire Improves Patient Outcome

Sickle-Cell Disease in Greece: Patient Reported Outcomes Related to Clinical Complications, Treatment Choices and Attitudes, Beliefs and Trends Affecting Potential Participation in Clinical Trials - a Greek National Multicentric Study

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Benefits of Aquatic Therapy in Pediatric Patients with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only